Signals are just the beginning. Fundz delivers what’s next.
Fundz reads more than a dozen live signals on every company, scores each one against your exact market, and weaves in your own network. Each morning you get the few worth your time: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Hcw Biologics announced it raised $1.5 Million in an initial filing from an offering of $1.5 Million
HCW Biologics is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions such as long-haul COVID-19.
Fundz sees it the moment HCW Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.